Spiral computed tomography screening: Study begins to determine its efficacy in lung cancer prevention

Por Kramer, Barnett S
Publicado em 2001

Paradoxes in carcinogenesis: New opportunities for research directions

Por Kramer Barnett S, Baker Stuart G
Publicado em 2007-08-01

The transitive fallacy for randomized trials: If A bests B and B bests C in separate trials, is A better than C?

Por Baker, Stuart G, Kramer, Barnett S
Publicado em 2002

Randomized trials, generalizability, and meta-analysis: Graphical insights for binary outcomes

Por Baker, Stuart G, Kramer, Barnett S
Publicado em 2003

A perfect correlate does not a surrogate make

Por Baker, Stuart G, Kramer, Barnett S
Publicado em 2003

Correction: The transitive fallacy for randomized trials: If A bests B and B bests C in separate trials, is A better than C?

Por Baker, Stuart G, Kramer, Barnett S
Publicado em 2003

Identifying genes that contribute most to good classification in microarrays

Por Baker, Stuart G, Kramer, Barnett S
Publicado em 2006

Paradoxes in carcinogenesis: New opportunities for research directions

Por Baker, Stuart G, Kramer, Barnett S
Publicado em 2007

Using microarrays to study the microenvironment in tumor biology: The crucial role of statistics

Por Baker, Stuart G., Kramer, Barnett S.
Publicado em 2008

Systems Biology and Cancer: Promises and Perils

Por Baker, Stuart G., Kramer, Barnett S.
Publicado em 2011

Surrogate Endpoint Analysis: An Exercise in Extrapolation

Por Baker, Stuart G., Kramer, Barnett S.
Publicado em 2013

The risky reliance on small surrogate endpoint studies when planning a large prevention trial

Por Baker, Stuart G., Kramer, Barnett S.
Publicado em 2012

Evaluating surrogate endpoints, prognostic markers, and predictive markers — some simple themes

Por Baker, Stuart G., Kramer, Barnett S.
Publicado no Clin Trials (2014)

Evaluating Prognostic Markers Using Relative Utility Curves and Test Tradeoffs

Por Baker, Stuart G., Kramer, Barnett S.
Publicado no J Clin Oncol (2015)

Lung Cancer Risk and Demographic Characteristics of Current 20–29 Pack-Year Smokers: Implications for Screening

Por Pinsky, Paul F., Kramer, Barnett S.
Publicado no J Natl Cancer Inst (2015)

Cancer Prevention: Lessons Learned and Future Directions

Por Dunn, Barbara K., Kramer, Barnett S.
Publicado no Trends Cancer (2016)

The fallacy of enrolling only high-risk subjects in cancer prevention trials: Is there a "free lunch"?

Por Corle Donald, Kramer Barnett S, Baker Stuart G
Publicado em 2004-10-01

The Paired Availability Design for Historical Controls

Por Baker, Stuart G, Lindeman, Karen S, Kramer, Barnett S
Publicado em 2001

Markers for early detection of cancer: Statistical guidelines for nested case-control studies

Por Baker, Stuart G, Kramer, Barnett S, Srivastava, Sudhir
Publicado em 2002

Estimating the cumulative risk of false positive cancer screenings

Por Baker, Stuart G, Erwin, Diane, Kramer, Barnett S
Publicado em 2003